The Promise of Adipose Stem Cell Therapy in Functional Medicine

The Promise of Adipose Stem Cell Therapy in Functional Medicine

with Kristen Comella, PhD – Stem Cell Researcher and Chief Science Officer of BioHealth, LLc.

The Talk

The field of regenerative medicine is rapidly growing with an emphasis on stem cell therapies and the promise of cures for everything from acute injuries to chronic degenerative diseases. The list of indications is expanding as more studies are published to demonstrate safety and efficacy. Regenerative medicine is the process of replacing or regenerating human cells, tissues or organs to restore or establish normal function. The concept is that damaged tissue can be restored by using the body’s own healing mechanism to promote repair.

This new branch of medicine may change the course of chronic diseases and standard clinical therapies. However, with any new therapies, this must be approached cautiously and with scientific data to support the treatment. This session will discuss the current in-clinic applications of stem cell therapies in degenerative diseases and the challenges of bringing these products to patients.

About the Speaker

Ms. Comella has over 15 years’ in regenerative medicine. She was recently named number 24 according to Terrapin’s list of the Top 50 Global Stem Cell Influencers. Ms. Comella has pioneered a variety of stem cell therapies including cord blood derived cells, bone marrow cells, muscle cells and adipose cells for use in many different applications. She has developed a wide range of regenerative products and techniques that have been successfully implemented into the clinic. She also led the team that gained the first ever FDA approval for clinical trials using a combined cell and gene therapy product. Ms. Comella is currently serving as the Chief Scientific Officer and board member.  She was co-founder and Chief Executive Officer of Stemlogix, LLC for veterinary medicine. Previously, she worked as a research engineer for Osiris Therapeutics developing stem cell therapies for osteoarthritis. Ms. Comella holds an M.S. in Chemical Engineering from The Ohio State University and a B.S. in Chemical Engineering from the University of South Florida.

CME CREDITS: 2 Hours 

Cost: $20 for FMANT Members CLICK HERE TO RESERVE YOUR SPOT!

$45 for Non-Members CLICK HERE TO RESERVE YOUR SPOT!

Questions: betty@livingwelldallas.com

Location Sponsor